Stryker Corporation SYK
272.36
2.61
0.97%
as of 25 Sep
- Market cap
- $103.9B
- P/E
- 28.0×
Follow SYK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Stryker Corporation (SYK) P/S ratio
As of 25 September 2026, Stryker Corporation (SYK) trades at a P/S ratio of 4.0×. Over the past ten years it has ranged from 3.2× (March 2020) to 6.8× (April 2021); the current reading is higher than 14% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 5.3× | (11.90%) |
| FY2024 | 6.1× | 10.67% |
| FY2023 | 5.5× | 8.77% |
| FY2022 | 5.0× | (14.41%) |
| FY2021 | 5.9× | (8.09%) |
| FY2020 | 6.4× | 21.54% |
| FY2019 | 5.3× | 22.35% |
| FY2018 | 4.3× | (9.15%) |
| FY2017 | 4.7× | 20.29% |
| FY2016 | 3.9× | 12.11% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 4.7× | (6.14%) |
| Mar 2026 | 5.0× | (6.91%) |
| Dec 2025 | 5.3× | (7.75%) |
| Sep 2025 | 5.8× | (8.67%) |
| 42 more quarters | Free account |
Against its own ten years
Low 3.2×
High 6.8×
Ten-year median
5.1×
Current reading's percentile
14
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.2× |
| GEHC GE HealthCare Technologies Inc. compare | 1.4× |
| MDT Medtronic PLC compare | 3.0× |
| BSX Boston Scientific Corporation compare | 3.1× |
| STE STERIS plc compare | 3.4× |
| ABT Abbott Laboratories compare | 3.8× |
| SYK Stryker Corporation | 4.0× |
| DXCM DexCom, Inc. compare | 6.7× |
| EW Edwards Lifesciences Corporation compare | 7.6× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on SYK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement